PCM
BHVN icon

Prelude Capital Management’s Biohaven BHVN Stock Holding History

Prelude Capital Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-31,356
Closed -$754K – 1023
2025
Q1 		$754K Buy
31,356
+22,953
+273% +$809K 0.06% 381
2024
Q4 		$314K Buy
+8,403
New +$392K 0.02% 779
2024
Q3 		– Sell
-11,000
Closed -$382K – 1286
2024
Q2 		$382K Buy
11,000
+3,100
+39% +$123K 0.03% 674
2024
Q1 		$432K Buy
+7,900
New +$391K 0.02% 697
2023
Q4 		– Sell
-9,067
Closed -$236K – 1138
2023
Q3 		$236K Sell
9,067
-1,000
-10% -$20.8K 0.02% 807
2023
Q2 		$241K Buy
+10,067
New +$173K 0.02% 752

Other funds holding BHVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Prelude Capital Management's BHVN Position: Q2 2025 in Review

Prelude Capital Management sold out of Biohaven (BHVN) in Q2 2025, closing a stake of 31,356 shares — an estimated $754K sold.

Prelude Capital Management first reported a position in BHVN in Q2 2023 and held it in 6 quarters. The position peaked at $754K in Q1 2025. 249 funds tracked by Wall St. Rank hold BHVN as of Q2 2025.

  • Prelude Capital Management reported no remaining Biohaven position as of Q2 2025 after selling out during the quarter.
  • Prelude Capital Management sold 31,356 Biohaven shares in Q2 2025, an estimated $754K.
  • Prelude Capital Management first reported a position in Biohaven in Q2 2023 and held it in 6 quarters.
  • Prelude Capital Management's Biohaven position peaked at $754K in Q1 2025.
  • 249 funds tracked by Wall St. Rank held Biohaven as of Q2 2025.

Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.